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ABSTRACT
The modified/regulated drug delivery system helps to sustain the delivery of the drug for a prolonged period. The modified drug delivery system 
is primarily aimed at ensuring protection, the effectiveness of the drug, and patient compliance. The transdermal drug delivery system (TDDS) falls 
within the modified drug delivery system, in which the goal is to deliver the drug at a fixed dose and regulated rate through the skin. Polymers are the 
backbone of the framework for providing transdermal systems. The polymer should be stable, non-toxic, economical, and provide a sustainable release 
of the drug. In general, natural polymers used in the TDDS as rate-controlling agents, protective, and stabilizing agents and also used to minimize the 
frequency of dosing and improve the drug’s effectiveness by localizing at the site of action. Nowadays, manufacturers are likely to use natural polymers 
due to many issues associated with drug release and side effects with synthetic polymers. Drug release processes from natural polymers include 
oxidation, diffusion, and swelling. Natural polymers may be used as the basis to achieve predetermined drug distribution throughout the body. The 
use of natural materials for traditional and modern types of dosage forms are gums, mucilages, resins, and plant waste etc. Thus, the main objective of 
this review article is to give a brief knowledge about the extraction, modification, characterization, and biomedical application of conventional natural 
polymers used in the transdermal drug delivery system and their future prospective.
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INTRODUCTION
Polymer is an essential part of any matrix drug delivery systems. Polymers 
are used for the various drug delivery systems, provide thickness, 
consistency, and volume and also provide multifunctional stability, drug 
release, proper targeting, improved biological compatibility, and patient 
compliance [1]. Choosing a polymer because of the inherent complexity 
of structures requires a comprehensive understanding of the surface 
and bulk properties of polymers so that it can produce the desired 
functionality [2]. In the preparation of the transdermal drug delivery 
system (TDDS), both natural and synthetic polymers can be used. 
Biodegradable polymers are generally high molecular weight materials 
from natural sources such as plants, microorganisms, and animals. 
Natural polymers are preferred compared to synthetic polymer [3] due 
to its low toxicity, renewability, versatility to modify, biodegradability, 
and low cost [3]. Natural polysaccharide polymers are hydrophilic, 
enzymatically degradable, and are capable of maintaining the stability of 
protein drugs embedded in them and also increasing their therapeutic 
efficacy [4]. The polysaccharide polymers are biocompatible and 
interact with living cells, which makes them compliant and appropriate 
biomaterials for long systemic circulation and targeted drug delivery 
systems [5]. In general, most natural polymers are considered safe for 
oral use and therefore find applications in the food and pharmaceutical 
industries. Extracting and developing polymers from natural sources 
can reduce regulatory approval requirements [6]. The seasonal result, 
location/climate, soil variability, and stability as they lack viscosity 
or distortion during storage, etc., are some of the difficulties of 
using natural polymers [6]. These problems and the petrochemicals 
revolution led to the growing use of synthetic polymers, slowly 
nudged to the background of natural polymers. Synthetic polymers 
are comfortable and endeavored to drug delivery scientists because of 
their physicochemical properties [6]. The increasing concern about bio-
incompatibility, toxicity, etc., factors led to natural polymers revisited 
repeatedly in the pharmaceutical field. In recent times, the use of natural 
polymers has increased due to the support of “green chemistry” and 
technology materials [6]. Natural polymers are biogenic, and their 
biological properties such as cell recognition and interactions, enzymatic 
degradation, extracellular matrix-like appearance, and chemical 
stability make them materials of choice for drug delivery [6]. The natural 
polymers have the varieties of role in the drug delivery system such as 
emulsification [7], suspension [8], retarding the drug release [9], film 
coating [10], disintegration [11], solubilization, bioadhesion, gelling, 
thickening, viscosity modulation, bulking agent [12], drug encapsulation, 
and mechanical enhancer [13-15]. The use of natural polymers in the 
targeted drug delivery system is also increasing day by day. Increasing 
the use of natural polymers in drug delivery means an increase in 
demand, which indicates the need for research and development into 
new natural polymers or modification of old polymers for subsequent 
marketing [15]. This review article gives a piece of detailed information 
about the extraction, modification, characterization, and biomedical 
application of conventional natural polymers used in the TDDS and their 
future prospective.
DESCRIPTION ABOUT TDDS
The transdermal drug delivery system is characterized as a medicated 
adhesive patch or film system which is mounted over the skin’s surface 
to deliver a predetermined dose of the drug over a extended period [16]. 
The delivery of drugs in a controlled manner through the skin is the 
most challenging field. Thus, the technique for the controlled release of 
drugs through TDDS is more efficient, appealing, and successful [16]. 
The transdermal patch shows to be beneficial compared to other drug 
delivery system, due to the following reasons [16-26]:
•	 This provides patients with safety, secure, and painless self-
administration
•	 TDDS can be useful in poly-medicated patients
•	 TDDS provides a constant rate of drug release to an extended period 
to prevent dose dumping and therapeutic index problems associated 
with oral dose and parenteral administration
•	 TDDS patches enhanced the therapeutic effects of different 
medications by preventing common drug-related problems such as 
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first-pass metabolism, toxic metabolite formation, poor absorption, 
gastrointestinal irritation, etc.
•	 TDDS is useful for medications that have a short half-life to prevent 
repeated dosing
•	 Simplified medicines reduce inter and intra-patient variability
•	 For unconscious patients with dysphagia or constipation, TDDS has 
a more significant advantage
•	 Avoiding of pre-systemic metabolism leads to a reduction in the 
amount and, thus, a reduction in adverse effects in acute liver 
toxicity
•	 The absorption of the drug can be terminated by withdrawing 
transdermal devices at any point in time
•	 TDDS is usually cost-effective as patches, designed to deliver 1–7-day 
medications as compared with other treatments
•	 In comparison with the nasal cavity, it provides a relatively wide 
range of applications [16-26].
Limitations of TDDS
•	 The drug molecule with a large molecular size is not suitable for 
transdermal delivery (> 1000 Dalton approx.)
•	 The medication must have specific physicochemical properties 
for skin penetration, and if the dosage of a drug is high, i.e., it is 
challenging to deliver more than 10–25 mg/day by transdermal. The 
preferred average drug dosage is below 5 mg/days
•	 The drug or the excipients used in the formulations may result in 
local irritation at the site of administration such as itching, erythema, 
and local edema
•	 Clinical trial is required before applying the transdermal patches to 
the skin surface
•	 At the site of operation, most patients experience dermatitis due to 
system components
•	 The barrier function of the skin changes from one person to another 
person depending upon the age and the location from where they 
belong
•	 Low skin permeability limits the number of medicines available in 
this way
•	 TDDS is not an appropriate system to deliver the ionic drug molecules
•	 Hormones are not the suitable candidates to deliver through the 
transdermal route [16-26].
Building blocks of TDDS
Rate controlling membrane
The TDDS regulates the drug release property by dispersing into a 
matrix of inert polymers. The polymer powder blended physically with 
drug moiety and then molded to get the desired thickness and surface 
area [23-26].
Selection of model drug
•	 It is expected to be therapeutically active (dose in mg), with a 
molecular weight of about maximum 1000 Da.
•	 The drug should be soluble in the vehicle and the log p value of as 
much as 5.
Transdermal drug delivery has now become increasingly widespread. 
For the production of transdermal network, various physicochemical, 
pharmacokinetic, and pharmacological properties of the drug should 
be considered because of the skin’s permeability, and drugs must be 
transdermally distributed through the skin by passive diffusion and 
constrained by several significant restrictions [24].
Pressure sensitive adhesive
Pressure-sensitive adhesive makes direct contact between the 
skin and the transdermal system, and holds the drug in solution 
or suspension form in the system. The consistency of the drug 
spreading mainly depends on the applied force [23]. The rapidity 
of the transdermal device can be achieved by adhesive immune 
to strain. Examples include polyisobutylene, polyacrylate, and 
silicones [24].
Release liners
A patch is usually protected by waterproof padding which is incorporated 
during preparation. The release liner is removed only before applying 
the patch on the skin surface because the release liner is in direct contact 
with the transdermal system, therefore, both physically and chemically 
inert. The release liner consists of a base layer that can be non-occlusive 
(e.g., paper fabric) or occlusive (e.g., polyethylene and polyvinylchloride) 
and a silicone or Teflon release covering sheet. Specific components 
used in transdermal patches as release liners include polyester foil and 
metalized laminate [24-26].
Backing laminate
The following points must be taken into account during the formation 
of the baking layer:
•	 It must be versatile and non-toxic
•	 Getting a low transmission rate of water vapor to facilitate hydration 
of the skin and thus helps to increase the skin permeability of drugs
•	 This should be consistent with the transdermal device because it is 
still in use throughout the operation
•	 It must have strong tensile resistance [24].
For example, polyethylene film, polyester film and polyolefin film, and 
aluminum vapor-coated layer.
Penetration enhancers
The compounds that facilitate penetration of topically used drugs are 
typically called absorption boosters, accelerators, or penetration enhancers. 
They are used in a solution to enhance diffusiveness, and solubility, thereby, 
helps to reduce the skin’s barrier resistance reversibly [24].
For example, hydrocarbons, alcohols, acids, amines, amides, esters, 
surfactant, terpenes, terpenoids, essential oil, sulfoxides, lipids, and 
miscellaneous such as cyclodextrin derivatives and chitosan.
Desired properties for penetration enhancers
•	 The penetration enhancer must be non-irritating, non-sensitizing, 
non-phototoxic, and non-comedogenic
•	 Initiation action should be immediate and the operation period 
should be consistent and repeatable
•	 They should not have any pharmacological activity in the body, i.e., 
should not bind to the surface of the receptor
•	 When the enhancer withdrew, the upper layer regains its natural 
barrier properties wholly and automatically
•	 The accelerants to be used in topical formulations and system should 
be chemically and physically consistent with all medications and 
adjuvants
•	 This should be readily incorporated into preparations for effective 
dermatological activity. It should have an optimal parameter of 
solubility that is comparable to that of the skin
•	 This should stick to the skin surface and spread well when 
applied [23,24].
Plasticizers and solvent
For transdermal formulations, plasticizers ranging from 5% to 
20% (w/w, dry base) have also been used. The plasticizers are also 
responsible for film adhesiveness to other surfaces or membranes 
and for increasing the film strength along with the film’s brittleness 
and ductility [23,24,26]. For example, 15% w/w of glycerol or sorbitol, 
dry basis, phosphate, phthalate esters, fatty acid esters, and glycol 
derivatives such as polyethylene glycol (PEG) 200 and PEG 400 is 
generally used for plasticity. Solvents are used for product reservoir 
preparation [23,26]. For example, methanol, chloroform, acetone, 
isopropanol, dichloromethane, etc.
SOURCES OF NATURAL POLYMERS
Natural polymer has undoubtedly become an interest in the drug 
delivery system due to its physicochemical properties [27]. The 
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polymers derived from plants (e.g., pectin, guar gum, and mannan), 
microbes (e.g., dextran and xanthan gum), and animals (e.g., chitosan or 
chondroitin), has been found in abundance in the atmosphere and can 
also be readily re-producible using recombinant DNA technology [27]. 
The monosaccharide polymers have a wide range of beneficial properties 
such as high stability, non-toxicity, hydrophilicity, biodegradability, gel-
forming ability, and chemical modification ease [27]. There is a range 
of structural compositions of plant polysaccharides that are related not 
only to different plants but also to the portion of plants they derived 
from such as leaves, seeds, roots, and tubers. Two particular structural 
features can clarify the complexity and variety of polysaccharides: First, 
monosaccharides can be bound differently in α or β configuration; 
second, due to the branched side chains [27]. The natural polymers 
consisting of amino acids are somewhat uniform in size, and there is no 
variation. Such polymers are said to be homogeneous or monodisperse. 
In general, the natural polymers made by condensation polymerization 
techniques. Natural polymers tend to be readily biodegradable, and 
they show no adverse effects on the environment or human beings [27]. 
Depending upon the sources, natural polymers classified into three 
major categories, depicted in Fig. 1.
EXTRACTION AND PURIFICATION OF NATURAL POLYMERS USED 
FOR TDDS
The macerated plant parts (calyxes, leaves, stump barks, roots, seeds, 
or fruits) are the primary extract that should be warm in water over 
some time [28]. Then, by filtration technique (using a muslin cloth), 
the gum or mucilage is separated from the part of the plant. By adding 
alcohol, the mucilage or gum is precipitated out of water. Absolute 
ethanol typically used because it precipitates faster and gives higher 
yields than gasoline: water mixture. Furthermore, ethanol is a preferred 
solvent for any extraction process and has also approved by the Food 
and Drug Administration (FDA) [28]. For precipitation, other solvents 
such as acetone and methanol can also be used effectively. Mucilage 
is air-dried or oven-dried after precipitation [28]. Seeds of Mimosa 
pudica have macerated for 10 h in sufficient water. The mucilage that 
was collected, including the seeds, was then dried in the oven for 4–5 
h at 50°C. Passing through No. 18 sieve, dried mucilage was isolated 
from the seed husks. The seed husks were subsequently removed with 
winnowing by the freeze-drying method rather than heating [29,30].
Mucilage extraction from Plantago psyllium seed was successful by 
adding the seeds to boiling 0.1 M HCl until the seed husk dissolves [31]. 
Once the color has changed for all the seeds, the filtration is performed 
and separated. The concentrated filtrate is combined with ethanol to 
precipitate the mucilage and finally dried [31]. Forsskaolea mucilage 
obtained by soaking the seed husk in deionized water at 80°C 
continuously with 2 h ripening [32]. It is then allowed to cool at room 
temperature and left overnight. Upon stirring, 0.5 M NaOH is added to 
separate out the mucilage from the seeds, and the resulting slurry is 
filtered. The mucilage is precipitated on the filtrate by adding 2 M HCl. 
Centrifugation of the residue is then carried out to remove the water 
and acid residues and finally dried [32].
Sesamum indicum/Sesamum radiatum mucilage is extracted by 
proclaiming weighted leaves into hot water for 6 h and is then 
washed with a bag of muslin. It is then precipitated and cleaned with 
ethanol [3]. It’s dried and milled with salt. Recent extraction in the 
laboratory indicated that mucilage could be effective when extracted 
with cold water from the leaves [3]. It has also been found that mucilage 
browning was less with cold water. In addition, sodium metabisulfite 
(1% w/v) is used as a bleaching agent/antioxidant during maceration 
that prevents enzymatic browning [3].
Cashew is an exudate from the Anacardium occidentale tree bark. The 
gum is milled, dissolved in water, and filtered after processing and dried. 
Alcoholic solvents are generally added in the filtrate to precipitate and 
then dried in a hot air oven at 45°C [32]. The isolates cashew gum is 
dissolved in water and centrifuged to obtain precipitation faster. The 
supernatant stored for drying [32]. First, defatting achieved for parts of 
the plant, such as tubers with petroleum ether and saponins extracted 
with methanol before maceration [33].
Nevertheless, some researchers did not attempt to extract saponins from 
tubers such as Eulophia campestris because they preferred to extract 
mucilage rather than saponins [34]. Mucilage from E. campestris tubers 
extracted by boiling in water for 1 h and then precipitated with acetone, 
and finally dried the mucilage [34]. It may not be necessary to initially 
defeat and extract saponins as fat dissolves in acetone and ethanol, which 
are the common solvents used in mucilage and gum precipitation. In 
contrast, saponins dissolve in ethanol and a mixture of water and acetone; 
this means that during precipitation, fat and saponins are separated from 
the mucilage [34]. Hence, distilled gums and mucilage obtained by water 
maceration and subsequent precipitation over a while using organic 
solvents such as ethanol, acetone, and isopropanol, combined with several 
soakings and washing in organic solvents. This process influenced by 
various factors such as part of the plant, the position of the mucilage, 
method of separation, choice of solvents for extraction, and choice of 
drying technique [34]. The schematic diagram showed in Fig. 2 explained 
the general process of extraction of natural polymers.
Some washings and precipitations using solvents, including ethanol, 
acetone, and isopropanol, can able to purify the derived polymer, thus 
remove impurities [34]. Nevertheless, a liquid chromatography-mass 
spectrometry purification method used to perform further purification 
if needed [34]. As far as microbes are concerned, pure ethanol widely 
Fig. 1: Based on the sources, classification of natural polymer and their examples
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used for extraction and purification [34]. Absolute ethanol inactivates 
the bacteria, but the microbes reactivate in the presence of favorable 
conditions and can contribute to polymer degradation. One of the 
drawbacks of renewable polymers is microbial degradation [34]. Some 
of the natural polymers, including chitosan and aloe vera mucilage, 
exhibit antimicrobial activity so that no microbial contamination can 
occur. The microbial load can be easily calculated using traditional 
microbiological measures. Therefore, polymers can be sterilized 
depending on use [35]. Sterilization methods include filtration, use 
of ethylene oxide or hydrogen peroxide, 70% ethanol (resistant to 
hydrophilic viruses and bacterial spores), gamma irradiation, and 
low-temperature radiofrequency glow discharge plasma treatment 
can be used for polymer sterilization process [35]. To prevent polymer 
degradation, morphological changes, chemical damage, the choice of 
sterilization technique is paramount [35].
MODIFICATION OF NATURAL POLYMERS BY VARIOUS 
TECHNIQUES
Natural polymers improved as a way of overcoming their drawbacks 
such as viscosity, microbial degradation, and partial or low solubility. 
Furthermore, altering existing polymers improves their properties 
and flexibility in the delivery system. Reformation should be made in 
such a way that the existing polymers do not sacrifice their physical/
biological properties. Modification methods include grafting, cross-
linking, derivative formation, and blending of polymer-polymers [36].
Grafting and Cross-linking
Singh and Chauhan synthesized a polymer network of psyllium husk and 
methacrylamide (MAAm) with ammonium persulfate (APS) used as an 
initiator and N, N-methylene-bisacrylamide (N, N-MBAAm) used as an 
cross-linking agent [36]. The synthesis carried out through a free-radical 
process followed by chemically induced polymerization. The ammonium 
persulfate has developed reactive psyllium in MAAm and N, N-MBAAm 
site chains. The four reactive sites on N, N-MBAAm can be connected to 
the psyllium and poly radicals (MAAm) to create a three-dimensional 
(3D) psy-cl-poly (MAAm) hydrogel. Insulin is introduced in the hydrogel 
with a proper swelling balance process. Afterward, the hydrogel swelled 
and dried to obtain an insulin-loaded polymer matrix system. The 
polymer matrix was evaluated at predetermined time for swelling and 
release of the drug [36]. The swelling and release of the drug occurred at 
a higher rate with neutral pH than acidic pH environment, but the release 
from the hydrogel still modulated with differences in the structure of 
polymer network and cross-linker used [36].
Moreover, psyllium polymeric network was synthesized by using 
N-hydroxymethyl acrylamide, and N, N-MBAAm used as cross-linkers, 
and salicylic acids and tetracycline hydrochlorides used as model 
drugs [37]. Besides, hydrogels based on psyllium-N-vinylpyrrolidone 
was also obtained by radiation mediated cross-linking process and 
5-fluorouracil was used as a model drug in that preparation [38]. In 
another study, methacrylic acid and sterculia gum have modified using 
APS as the initiator, and N, N-MBAAm used as a hydrogel generating 
cross-linking agent [39].
Sterculia gum and modified sterculia-cl-poly (MAAc) were 
characterized for swelling ability, drug release, morphological, and 
structural alteration [40]. A comparison study revealed that sterculia-
cl-poly (MAAc) has demonstrated morphological variability as opposed 
to the smooth and homogenous sterculia gum. The swelling was 
analyzed according to the parameters of the reaction. The authors 
noted that sterculia-cl-poly swelling (MAAc) was decreased as the 
concentration of monomers in the polymer matrix increased [40]. In 
addition, sterculia-cl-poly (MAAc) swelling was increased with an 
increase in APS concentration (used as initiator) and decreased with 
an increase in N, N-MBAAm concentration. Swelling also increased with 
an increase in sterculia gum [40]. In the aqueous medium, swelling is 
depending on matrix retention time. In comparison, with an increase 
in pH, swelling increased and decreased by 0.9% NaCl. While swelling 
increased as pH grew, drug release rates were higher at lower pH 2.2. 
This was attributed to the accelerated solubility of the drug ranitidine at 
lower pH. The authors have changed the sterculia gum with acrylamide 
(AAm) and used the same initiator and cross-linker [40]. Many natural 
polymers grafting and cross-linking have been reported so far such as 
polyacrylamide grafted into Katira gum and Katira gum cross-linked 
with glutaraldehyde [41,42]; guar-gum cross-linkage with trisodium 
Fig. 2: Schematic diagram for the general extraction process of natural polymers
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trimetaphosphate [43]; and an epichlorohydrin cross-linked with 
cashew gum [44].
Formation of derivatives
Natural polymeric derivatives have found better physicochemical 
properties such as hydrophilicity, solubility, swell ability, drug release, 
stimulus-response, and film formation [14,45]. The natural polymeric 
derivative can be formed by various chemical techniques such as 
carboxymethylation, carbamoylethylation, cyanoethylation, acetylation, 
deacetylation, sulfation, phosphorylation, and esterification [14]. 
Carboxymethylation increases their solubility by adding carboxymethyl 
groups to the existing polymers. Natural polymers such as cashew 
gum [46], xyloglucan gum [47], locust bean gum [48], starch [49], 
hemicelluloses [50], konjac glucomannan [51], xylan [52], guar gum, 
and tara gum [53] have been carboxymethylated to increase their 
solubility [45]. Carboxymethylation was carried out by using aqueous 
and non-aqueous method [47,53]. The process of carboxymethylation 
using the aqueous method is determined by solvent structure, 
solvent composition, sodium hydroxide, monochloroacetic acid 
concentration, reaction time, and temperature of the reaction [47]. At 
the presence of sodium hydroxide, carbamoylethylation of mucilage 
and gum is done with AAm. The reaction parameters that affect the 
carbamoylethylation process include the gum-liquor ratio, sodium 
hydroxide, AAm concentrations, and reaction temperature [54]. 
Carbamoylethylation increases the properties of the gum, including 
water solubility, consistency, and clarity of solution [55]. For example, 
carbamoylethylated polysaccharides (mucilage and gum) include 
guar gum [54] and the cassia tora gum [53]. Cyanoethylation is 
another method used to alter the natural polymers and improve their 
solubility and chemical stability. In the presence of sodium hydroxide, 
the cyanoethylation process is performed with acrylonitrile. Thus, 
acrylonitrile and sodium hydroxide concentrations, temperature, and 
time of reaction are the parameters that affect the process [56]. Some 
of the examples of natural cyanoethylated polymers are cassia tora 
gum [56], tamarind kernel powder [57] etc.
Polymer-polymer blending
Polymer-polymer blending is an easy and comfortable way to change 
polymeric nature or form new polymers without the chemical reaction/
synthetical process [58]. The blending may occur due to physical bonding 
between two or more polymers at a time [58]. The mixing may also be due 
to chemical bonding, or covalent bonding (cross-linking) or ionic bonding 
interacting between the two or more polymers. Blending polymers is a 
way to boost the properties of the participating polymers [58]. A mixture 
of alginate, sapwood bean gum, and xanthan gum in microspherical 
drug delivery system improved the efficacy in drug trapping and further 
delayed the drug release compared to alginate and sapwood bean or 
alginate and xanthan gum mixture [58]. Microbeads made with an alginate 
and Irvingia gum combination have significantly improved the efficiency 
of drug loading and controlled the drug release over 7 h compared to 
alginate microbeads [59]. Natural and synthetic gum composites have 
also been used to create hydrogels, including carboxymethyl cellulose 
(CMC)/locust bean gum and methacrylate copolymers [60]. However, its 
interaction with CMC developed a hydrogel that enhances the mechanical 
strength of CMC [60].
CHARACTERIZATION OF NATURAL POLYMER
Plant mucilages and gums are mostly polysaccharides in nature. The 
structure, physicochemical, physicomechanical, and drug delivery 
properties need to thoroughly elucidate to advance the use of mucilages 
and gums from bench to pilot scale. It is also essential to distinguish 
between each natural polymer with others. The comprehensive 
characterization of a natural polymer can show its uniqueness and 
improve its use in pharmaceutical applications [61].
Structural elucidation of natural polymers
The identification of the polymer is usually done by determining the 
structure of the polymer. The properties of polymers depend on their 
chemical structure and chain conformations. While to fully elucidate a 
polymer’s structure and chain conformation, a wide range of techniques 
are available to describe and classify a polymer systematically [61]. 
Fourier transform infrared spectroscopy, liquid state nuclear magnetic 
resonance (NMR) (one and two dimensions), solid-state NMR, Raman 
spectroscopy, gas chromatography (GC), GC-mass spectroscopy (GC-
MS), and high-performance liquid chromatography are used to classify 
and identify the polymeric structures [61]. Polysaccharide chain 
conformations in solutions are elucidated by static and dynamic light 
dispersion, viscosity analysis, circular dichroism analysis, atomic force 
microscopy (AFM), single-molecule force spectroscopy based on AFM, 
fluorescence correlation spectroscopy, and NMR spectroscopy [61].
Identification of sugar constituents
The mucilage or gum is hydrolyzed with dilute acids to determine the 
sugar constituents [14]. Chromatographic techniques, including size 
exclusion chromatography with multi-angle laser light scattering, GC 
can able to isolate the various monosaccharides from gum and mucilage. 
Structural elucidation can also be done with NMR spectroscopy and 
MS [14]. Methylation, periodate, and lead tetra-acetate oxidation is 
elucidate the process of monosaccharide-monosaccharide bonding in 
polymer chemistry [14].
Polymorphism determination
An alteration in the polymeric structure can also change its degree of 
crystallinity, which further affects their properties such as solubility, 
stability, and drug release [29]. Various analytical techniques have been 
used to determine polymorphism such as gel electrophoresis, differential 
scanning calorimetry (DSC), wide-angle X-ray diffraction (XRD), and 
powder XRD [29]. However, the X-ray diffraction is the primary technique 
which is used to determine the degree of crystallinity of a polymer. 
Characteristic peaks reflect the degree of crystallinity in the obtained 
spectrum [29]. The lack of characteristic spectrum peaks is indicative 
of the polymer’s full amorphous existence [29]. The majority of natural 
polymers are either amorphous or semi-crystalline. The polymer, which 
is high-crystallinity in nature, is more soluble and vice-versa [62].
Determination of molecular weight and polydispersity index
The determination of polysaccharide’s molecular weights may 
be challenging due to their heterogeneity and polydispersity 
behavior [63]. Polysaccharide fractions of mucilage and gums can 
be observable by preparative chromatography, for example, scale 
exclusion chromatography (SEC), GC, and viscometer rheometric 
technique generally used for molecular weight and polydispersity 
determination [64]. The determination of viscosity gives a brief 
knowledge about the molecular weight as it is a direct molecular weight 
representation. The multi-angle laser light scattering is faster and more 
reliable when combined with chromatographic techniques, such as, Size 
exclusion chromatography (SEC) [65]. Summers et al. recently promotes 
the advanced polymer chromatography system that provides a better 
polymer distribution resolution with a shorter time-span to determine 
molecular weight distribution [65]. Nevertheless, the system also appears 
to be advocated for samples of low molecular weight polymer [65].
Surface characteristics of natural polymers
The surface morphology of a polymer or its derivative can affects the 
rate and mechanisms of drug release from the polymer [66]. The surface 
modification of a polymer is used to screen the drugs [66]. A polymer 
(modified or natural polymer) morphology also affects the degree and 
length of its circulation through blood, polymer-drug interaction, or nano 
or micro-particle-cell interactions or cell encapsulation [67]. Hence, an 
understanding of the morphology of natural polymers such as shape, 
scale, and surface chemistry is imperative and can able to determine 
with scanning tunnel microscopy, transmission electron microscopy 
(TEM), scanning electron microscopy (SEM), and atomic force microscopy 
(AFM) [68]. TEM offers a two-dimensional view of a substance while SEM 
provides a 3D view and by exposing the molecular surface and mechanical 
properties, AFM takes it much further. TEM revealed that the particle 
is a nanocapsule with the inner ring display and SEM verified with the 
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hollowness display [68]. The application of technologies such as AFM and 
Raman spectroscopy improves polymer surface characterization. The 
topographical, electromagnetic, thermal, and near-field optical properties 
elucidated on the molecular scale are provided with high-resolution data 
of both chemical and morphological structures [68].
Thermal behavioral analysis
The physical and chemical changes of the polymer are generally 
identified by the DSC during the thermal processes. The polymer 
exposed by a range of temperatures and helps to identify the glass 
transition, crystallization, and decomposition nature of the polymer. 
Polymers act differently above and below their temperatures of glass 
transition [69]. The mechanical properties of the polymer also depend 
on the transition temperature [70]. Polymer thermal activity is distinct, 
and so each polymer is supposed to show a specific thermogram. 
Dynamic mechanical thermal analysis, thermally stimulated current 
spectroscopy, and dilatometry are other techniques used to analyze the 
polymeric thermal behavior [71].
Rheological behavior analysis of natural polymer
Another property based on molecular weight is the viscoelastic 
nature of the polymer. Viscoelastic properties of material contribute, 
for example the strength of the substance, stiffness, release of the 
drug, suspendability, and spreadability [72]. However, the rheometer 
measures the viscosity/flux as well as other parameters such as 
the impact of shear on polymer flow property, the effect of different 
Table 1: Biological source, composition, and uses of common natural polymers in drug delivery systems
Polymer Biological source Main component/s Uses in drug delivery systems Reference
Gum Arabic/
Gum Acacia
Acacia senegal  
(Family-Leguminosae) or 
Acacia arabica  
(Family-Combretaceae)
Composed of 1, 3-Galactopyranosyle β-D 
components, arabinose, glucuronic acid, 
rhamnose, and monosaccharide sugars
Suspending agent, emulsifying agent, 
binding agent, adhesive agent, emollients 
for cosmetics
[74-77]
Agar Gelidium amansii (Family-
Gracilariaceae)
Combination of agarose and agaropectin Suspending agent, emulsifying agent, 
supportive gelling agent, surgical lubricant, 
disintegrating agent, bacterial culture fluid, 
laxative medium
[71,78]
Tamarind Gum Tamarindus indica 
(Family-Leguminosae)
Consists of (1, 4)-β-D-glucan, α-D-
xylopyranose
Hydrogel, mucoadhesive agent, binding 
agent, emulsifying agent, suspending agent, 
high thermal stability
[79]
Moringa gum M. oleifera (Family-
Moringaceae)
Arabinose, galactose, and glucuronic 
acid
Gelling agent, binder, release retardant, 
lightweight, M. oleifera butter is used for 
baby products to provide a free, radical-
resistant, emollient
[80]
Guar Gum Cyamopsis tetragonolobus 
(Family-Leguminosae)
Polysaccharide made up of (1 
to 4)-Diequatorially associated 
β-Dmannoses monomers, β-1,4 
connected- D-mannopyranoses
Controlled release property, tablet excipient, 
release retardant
[81]
Tragacanth Astragalus gummifer 
(Family-Leguminosae)
Tragacanthin (composed of 
Tragacanthic acid and arabinogalactan), 
Orin, D-galacturonic acid, D-xylose, 
L-fructose, D-galactose





Ceratonia siliqua  
(Family-Leguminosae)
Galactomannan (80%), albumin and 
globulin (32%), glutelin (68%)
Binders, viscosity enhancers, stabilizers, 
matrix formers, drug release modifiers, 
coatings, disintegrators, solubilizers, 







Rhamnose, xylose, arabinose, glucose, 
galacturonic acid, pectic acid proteins, 
fats, calcium, and phosphorus
Bio adhesives, binder for tablets, strong 
insulator, absorption of water and swelling 
properties, film-forming ability
[84]
Rosin Pinus toeda  
(Family-Pinaceae)
Abietic acid, Pimaric acid Film coating agent, film-forming agent, 
release modifier, binding agent
[85]
Gum copal Agathis coranthifolia 
(Family-Araucariaceae)
Agathic acid, diterpenoid, Lobdane, 
cis-communicated acid, trans-
communicated acid
Binders, drug release modifiers, film 
coater, viscosity enhancers, stabilizers, 
disintegrates, solubilizes, emulsifiers, 
suspending agents, gelling agents, and 
bioadhesives
[86]
Gum Damar Shorea wiesneri  
(Family-Dipterocarpaceae)
α-resin (40%), β-resin (22%), 
Dammarolic acid (23%)
Binding agent, film-forming agent, 
bioadhesive agents, release retardant
[87]
Pectin Citrus limon (Family-
Rutaceae)
Ester of a (1→4) linked (+) – 
polygalacturonate sequences 
interrupted with (1–2) – (–) – rhamnose 
residues, (+) – galactose, (–) –arabinose, 
(+) – xylose, and (–) – fructose
Drug delivery, gene delivery, wound 
healing, tissue engineering, TDDS, hydrogel 
formation
[88,89]
Alginates Macrocystis pyrifera, 
Laminaria digitata, and 
Laminaria saccharina 
(Family-Laminariaceae)
Copolymer of D-mannuronic acid (M) 
and L-guluronic acid
Drug delivery, tissue engineering, wound 
healing, release retardant, disintegrating 
agent
[90,91]
Xanthan Gum Xanthomonas 
campestris (Family-
Xanthomonadaceae)
D-glucosyl, D-mannosyl, and 
D-glucuronyl acid residues
Cosmetics, drug delivery, water treatments, 
TDDSs
[92,93]
TDDS: Transdermal drug delivery system, M. oleifera: Moringa oleifera
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Characteristic Limitations Applications Reference





is high at solid 
concentration
- [94]
Agar Eserine and 
Pralidoxime 
chloride
- Role of agar in TDDS 
as a nutrient for 
bacterial growth to 
conduct Ames and 
Whitfield spot test
High gel strength at 
low concentrations 




Eserine is used 
in glaucoma and 
pralidoxime chloride is 





Clindamycin 1% w/w Role of extracts from 
Tamarind seeds 
as a novel gelling 
agent for TDDS and 
it works as release 
retardant
It has excellent 
physical properties 





A high viscous 
solution is formed 
when dissolved in 
water
Clindamycin 
phosphate is the most 
common topical. 
antibiotic used in the 
treatment of acne 
vulgaris
[96]
Moringa gum Tizanidine 
Hydrochloride













































of LBG helps to 
sustain the release 





Solubility is one 
of the major 









Acyclovir 20 mg Film-forming agent It has good film-












toxicity is present 








Gum copal Verapamil 
hydrochloride







for topical wound 
healing
Gum copal films 
are very much 
brittle in nature
Antianginal reduces 
high blood pressure 
and effective in 
migraine treatment
[103]
Gum Damar Diltiazem 
hydrochloride







Gum damar films 







Zein Ovalbumin 40 mg Film coating is the 
main function of 
zein in this patch
It is hydrophobic 
in nature, but it is 
made up of alcohol-
soluble protein of 
corn
Zein films are 
found to be brittle 
in the absence of 
plasticizers
Ovalbumin is an 
antigen that can be 
used to induce cystitis 
by initially sensitizing 
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frequencies or temperatures on polymers, and helps to understand the 
capacity of the polymer to behave as a viscous fluid, paste, gel, or a 3D 
network [72].
In vivo characterization of natural polymers
Some of the mucilages and gums can be edible, and some made from 
non-eating plant components. For instance, cashew nuts and fruits 
are consumed, but cashew gum is derived from bark. Toxicity and 
histopathology testing should be done to determine the safety and 
therapeutic efficacy of those gums and mucilages. The natural polymers 
used in the transdermal drug delivery system should be characterized 
in vivo before exposed to the skin surface. The transmucosal delivery of 
Hakea gum tablet was tested in vivo for their mucoadhesive properties 
[73]. The mucoadhesive property was tested ex vivo also, by which the 
tablet detachments were determined after pre-defined contact times 
between the tablet and hydrated intestinal mucosa from the newly 
excised rabbit intestinal mucosa. The strength required for detachment 
increased with contact time and the concentration of Hakea gum [73]. 
To assess the transmucosal distribution, the rabbits were anesthetized, 
Hakea buccal tablets were applied, and blood samples were collected 
from a cannula inserted into the marginal ear at fixed time intervals of 
more than 5 h. The chlorpheniramine (CPM) release was managed by 
Hakea gum and spread throughout 5 h. Moreover, during this time, a high 
concentration of CPM was given and sustained [73]. Nevertheless, the 
more concentration of Hakea gum, the more controlled the release and 
the subsequent reduction of Cmax and bioavailability of the incorporated 
drug [73]. The in vitro and in vivo characterization of the polymer must 
be studied before regulatory authorization for marketing [73].
Pectin Nicotine 2.5% 
w/w
Good film-forming 
ability and release 
modifier




agent and a good 
source of dietary 
fiber
- Nicotine is a 
































Clonidine 10 mg Maintain the 
stability of patch
High swelling ability, 
high thickening, 
binding, stabilizing 
and improve the 
solubility








or hydrogel to 
prepare matrix
Non-toxic, gelling 
agent with viscosity 
building properties
External stimulant 



































It is commonly used 
in the treatment of the 
cardiac and pulmonary 
disorders in premature 
infants and neonates
[112]
Polylactide TS 1 g (64 µg 
of TS per 
0.64 cm2)
Good controlled 





erosion profiles are 
present
Dose dumping and 
incompetent drug 
release property






5 mg of 
each drug
PHA works as a 




















Ketoprofen 23.94 mg Suitable membrane 





and well permeation 
capabilities are 
present
Swelling can be 
occurred
Analgesic in chronic 
pain conditions and 
for the acute and 
long-term treatment 
of rheumatoid 
arthritis and colonic 
adenocarcinoma
[115]
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Various natural gums and mucilage can be used as a natural polymer in 
biomedical applications, as mentioned in Table 1 and their application 
in the TDDS listed in Table 2.
ENVIRONMENTAL IMPACTS OF BIOPOLYMERS
Engineers are trying to integrate environmental considerations 
directly into material selection processes to increase awareness 
among the people about the necessity of environment in our society 
and its protection issues [116]. Manufacturing of polymeric materials 
through using renewable resources can be performed in two ways. 
First, there are two ways that are available such as natural cycles 
or intentional intervention by humans to replace the utilization of 
feedstocks. The second way is a biodegradable end product produced 
during the manufacturing of biopolymers from renewable feedstocks. 
At last, the biopolymeric materials are sent to the landfills for 
decomposition purposes because the degradation of biopolymers 
can be quickly processed rather than plastic, which is harmful to our 
environment [116].
FUTURE TRENDS
There are various beneficial advantages present for natural polymers 
over synthetic polymers such as natural polymers that are readily 
available, much cheaper than synthetic polymers, biodegradable, and 
chemical modification can be easily performed. Hence, the importance 
of natural polymers is increasing so rapidly in the drug delivery 
system for their beneficial effect rather than synthetic polymers [117]. 
Polymeric drug delivery system has the most exciting factor because 
drugs can be delivered through this process to the bloodstream at 
measured volume [117]. Some important macroscopic, microscopic 
structural, and chemical features are present in the natural polymers. 
Hence, most of the development in the controlled drug delivery system 
is focusing on the production and utilization of biopolymers [117].
Researchers or scientists want to increase the use of biopolymers 
not only in innovative drug delivery systems but also in other various 
sectors such as potential linings for artificial organs using as a substrate 
for cell growth or chemical reactors, as agents in drug targeting and 
immunology testing, also in biomedical adhesives, as separation 
membranes, and as substances in mimic biological systems. Hence, 
these newly modified biomaterials made up of tailor-made copolymers 
with desirable functional groups are rapidly manufactured by the 
researchers [118].
Production of novel supramolecular structures made up of polyethylene 
oxide copolymers and dendrimers is increasing rapidly because of their 
massive importance in the delivery of genes and macromolecules [118]. 
Finding the information about the chemical nature and physical 
structure of these new materials of biopolymers is very beneficial to 
increase the application of novel combinations of polymers in the new 
drug delivery system in the future [118]. The people of society always 
prefer safe materials and suitable processing methods from the initial 
synthesis of raw materials to the final disposal of a product that is very 
important in a product’s life cycle. Hence, a movement is growing among 
scientists and engineers to minimize or slash down the environmental 
impact of polymer composite production [118].
CONCLUSION
Biodegradable polymers are essential to delivering a wide range of 
active ingredients at the target site efficiently because biopolymers have 
profound side effects, the cost of production is low, and their potency is 
high in developing a new, advanced and effective drug delivery system. 
There are some upcoming modern mechanical techniques available 
to deliver the active ingredients through the transdermal system at 
the targeted area effectively, for example, X-ray lithography and LIGA 
(lithography, electroplating, and molding), mechanical array, electro 
oration, ultrasound, etc. Several issues found in the use of synthetic 
polymers for making a transdermal patch such as rash, inflammation, 
and crystallization of the active ingredients in the rate-controlling 
membrane during the permeation of drugs through the skin. Thus, 
more investigations are needed to perform on these types of polymers 
before they put out for commercial use. Polymers are the backbone of 
the TDDS, and some care needs to be taken during the production of 
the transdermal patch, such as toxicity determination, compatibility 
interaction studies between the polymer and drug molecule and 
also the degradation pattern before the selection of a polymer in the 
transdermal patch. The extraction, purification, and production of the 
natural polymer are less cost-effective than the synthetic polymer and 
may modify at a time to time. The degradation process of the natural 
polymer has easily occurred in the soil after its use in the transdermal 
patch. This article will help to improvise the knowledge about natural 
polymers used for the TDDS and create interest among the researchers 
to remodify the conventional natural polymers for future aspects.
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